Your session is about to expire
Cymbalta vs Luvox
Introduction
For patients with major depressive disorder (MDD) or other types of depression, certain medications can help stabilize mood and manage symptoms by altering the concentrations of neurotransmitters in the brain. Cymbalta and Luvox are two such drugs commonly prescribed for these conditions. Both impact different neurotransmitters but ultimately contribute to stabilizing mood fluctuations.
Cymbalta, also known as duloxetine, is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), which means it works by affecting both serotonin and norepinephrine levels in the brain. This dual action may be beneficial for managing depression alongside anxiety disorders and certain types of chronic pain.
On the other hand, Luvox, whose generic name is fluvoxamine, falls under the category of selective serotonin reuptake inhibitors (SSRIs). It primarily affects levels of serotonin in the brain. Luvox is often used not only to treat depression but also obsessive-compulsive disorder (OCD) due to its specific efficacy on serotonergic pathways.
Cymbalta vs Luvox Side By Side
| Attribute | Cymbalta | Luvox |
|---|---|---|
| Brand Name | Cymbalta | Luvox |
| Contraindications | Should not be taken with or have recently stopped taking monoamine oxidase inhibitors (MAOIs). | Should not be taken with or have recently stopped taking monoamine oxidase inhibitors (MAOIs). |
| Cost | For the brand name, approximately $270 for 30 capsules (60 mg). For the generic (duloxetine), costs range from $0.20 to $0.80 per day. | For the brand name, about $130 for 100 tablets (50 mg). For the generic (fluvoxamine), costs start at around $0.09/day and generally not exceeding about $0.70/day. |
| Generic Name | Duloxetine | Fluvoxamine |
| Most Serious Side Effect | Increased thoughts of self-harm or suicide, signs of an allergic reaction, changes in vision, fast or irregular heartbeat, low sodium levels. | Signs of an allergic reaction, worsening depression or unusual changes in mood, increased suicidal thoughts, racing heartbeats, unusual bruising, serotonin syndrome. |
| Severe Drug Interactions | Monoamine oxidase inhibitors (MAOIs). | Monoamine oxidase inhibitors (MAOIs). |
| Typical Dose | 20-60 mg/day for adults with MDD. Adolescents: start at 30 mg/day up to a max of 120mg/day. | Starts at 50 mg/day, up to 100-300 mg/day divided into two doses. Maximum dose for some patients is 300 mg/day. |
What is Cymbalta?
Duloxetine (the generic name for Cymbalta) is a part of the SNRI class of antidepressants which represents an important development from earlier classes of antidepressant drugs like SSRI. Duloxetine was first approved by the FDA in 2004. Cymbalta increases levels of both serotonin and norepinephrine by inhibiting their reabsorption, effectively maintaining them at higher levels in the brain than usual. It is prescribed for various conditions including major depressive disorder, generalized anxiety disorder, fibromyalgia and neuropathic pain. Unlike Fluvoxamine (Luvox), which principally affects serotonin neurotransmission, Duloxetine's influence extends to norepinephrine as well resulting in a broader spectrum of action but potentially more side effects due to its effect on two neurotransmitters instead of just one.
What conditions is Cymbalta approved to treat?
Cymbalta is approved for the treatment of various medical conditions, including:
- Major depressive disorder (MDD)
- Generalized anxiety disorder (GAD)
- Diabetic peripheral neuropathic pain
- Fibromyalgia
- Chronic musculoskeletal pain
On the other hand, Luvox is mainly used for the treatment of:
- Obsessive-compulsive disorders (OCD) It can also be used to treat depression; however, it's not its primary indication.
How does Cymbalta help with these illnesses?
Cymbalta, also known as duloxetine, helps manage conditions like depression and anxiety by increasing the levels of serotonin and norepinephrine in the synapses of the brain. This is achieved by inhibiting their reuptake into neurons, allowing these neurotransmitters to remain available for longer periods. Both serotonin and norepinephrine are neurotransmitters that play crucial roles in mood regulation, cognition, memory, sleep patterns among other physiological processes. It's generally accepted that individuals experiencing depression may have lower levels of these neurotransmitters. Therefore, by increasing both serotonin and norepinephrine availability through reuptake inhibition with a medication such as Cymbalta can help reduce symptoms associated with depression or anxiety disorders.
What is Luvox?
Luvox is a brand name for fluvoxamine, which is a selective serotonin reuptake inhibitor (SSRI), meaning it increases the levels of serotonin in the brain by reducing its reabsorption. By boosting this neurotransmitter, Luvox aids in maintaining mental balance and reduces symptoms of depression and anxiety disorders. It was first approved by the FDA in 1994.
As an SSRI antidepressant, Luvox primarily focuses on enhancing serotonergic activity without significantly affecting other neurotransmitters like norepinephrine or dopamine. This concentrated action means that its side-effect profile may be different from those of other classes of drugs used for similar purposes. Common side effects include drowsiness, nausea, and dry mouth but unlike some medications such as Cymbalta (a Serotonin-Norepinephrine Reuptake Inhibitor or SNRI), it is not known to cause significant weight gain or high blood pressure.
The potentiated serotonin effect can be beneficial for treating conditions like obsessive-compulsive disorder (OCD) and social anxiety disorder especially in patients who do not respond well to "typical" antidepressants that affect multiple neurotransmitters such as Cymbalta.
What conditions is Luvox approved to treat?
Luvox, also known as Fluvoxamine, is an antidepressant that's approved for the treatment of:
- Obsessive-compulsive disorder (OCD)
- Social anxiety disorders (social phobia)
It should be noted that although not specifically approved for this use by FDA, Luvox may be prescribed by healthcare providers to manage depression and other mood disorders. Always consult your doctor before starting any medication therapy.
How does Luvox help with these illnesses?
Serotonin is a neurotransmitter that plays important roles in many processes in the body, affecting mood regulation, sleep cycle, appetite and digestion. Low levels of serotonin have been implicated in depression and obsessive-compulsive disorder (OCD). Luvox works by increasing the levels of serotonin available in the brain, thereby alleviating some of the symptoms of these conditions. Its action on other neurotransmitters may also play a role in its efficacy as an antidepressant or anti-OCD medication. Since it primarily affects serotonin levels, it is often prescribed when a patient does not respond well to dual-action medications (such as Cymbalta), which affect both serotonin and norepinephrine levels; or it may be combined with them for enhanced effect.
How effective are both Cymbalta and Luvox?
Both duloxetine (Cymbalta) and fluvoxamine (Luvox) have established histories of successful treatment for depression, anxiety disorders, and other conditions. Duloxetine was approved by the FDA in 2004, while fluvoxamine received approval earlier, in 1994. These two drugs act on different neurotransmitters: duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), affecting both serotonin and norepinephrine levels in the brain; fluvoxamine is a selective serotonin reuptake inhibitor (SSRI), primarily affecting serotonin.
A double-blind clinical trial conducted in 2008 compared the efficacy of duloxetine to that of an SSRI medication similar to Luvox. The study found no significant differences between these two types of medications concerning their effectiveness at treating symptoms related to Major Depressive Disorder.
Duloxetine has been noted for its ability to alleviate physical pain associated with certain forms of depression starting from the first week of treatment – an advantage over many other antidepressants. It's also well-tolerated across diverse populations including elderly patients or those with chronic kidney disease. Further studies suggest optimal efficacy at doses around 60 mg/day.
On the other hand, fluvoxamine is often considered as a first-line option due to its fewer drug interactions relative to some SSRIs like Prozac or Paxil - making it potentially safer for polypharmacy patients who are already taking multiple medications simultaneously. This doesn't take away from its effective use against depressive symptoms but may be particularly beneficial for patients who need treatment specifically targeted toward obsessive-compulsive disorder (OCD). Despite this specificity, it still maintains robust evidence supporting its use as an effective stand-alone treatment option.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Cymbalta typically prescribed?
Oral dosages of Cymbalta range from 20-60 mg/day for the treatment of major depressive disorder in adults, with studies showing that a dose of 60 mg/day may be most effective. Adolescents between the ages of 13 and 17 should start at a dosage of 30 mg/day which can be increased up to a maximum dose of 120mg/day if there is no response after several weeks. On the other hand, Luvox is typically started at lower doses ranging from 25-50 mg/day for children and adolescents, and these can also be increased gradually over several weeks up to a recommended maximum dose of 200 mg/day depending on how well it's tolerated and its effectiveness.
At what dose is Luvox typically prescribed?
Luvox treatment typically begins at a dosage of 50 mg/day, taken at bedtime. The dose can then be increased to 100-300 mg/day, divided into two doses - one in the morning and one at night. For some patients, the maximum dose is raised to 300 mg/day divided into two equal doses if there is no response after several weeks of treatment initiation. It's important to note that Luvox should be titrated slowly with increments of 50mg over a week-long period because an abrupt increase might lead to adverse effects.
What are the most common side effects for Cymbalta?
Common side effects of Cymbalta and Luvox can vary, but may include:
- Nausea
- Dry mouth
- Constipation
- Loss of appetite
- Tiredness or drowsiness (somnolence)
- Sweating
- Insomnia
- Decreased sex drive, abnormal ejaculation/impotence (especially in males)
- Anxiety or nervousness
- Diarrhea
More severe symptoms such as gastrointestinal bleeding, serotonin syndrome characterized by agitation, hallucinations, rapid heartbeat have also been reported. It's important to note that not everyone who takes these medications will experience all of the above side effects. If you're considering either medication for treating your condition(s), it's crucial to discuss potential risks and benefits with your healthcare provider.
Are there any potential serious side effects for Cymbalta?
While Cymbalta and Luvox are both used to treat depression, anxiety and other related disorders, they do differ in their side effects. For Cymbalta, potentially serious symptoms include:
- Increased thoughts of self-harm or suicide
- Signs of an allergic reaction such as hives, difficulty breathing or swelling in the face or throat
- Changes in vision including blurriness or seeing halos around lights
- Fast or irregular heartbeat causing shortness of breath and sudden dizziness
- Low sodium levels leading to headaches, confusion, slurred speech, severe weakness and loss of coordination
On the other hand with Luvox you might experience signs of:
- Serotonin syndrome: agitation, hallucinations fever sweating shivering fast heart rate muscle stiffness twitching loss of coordination nausea vomiting diarrhea
- Severe skin reactions like a red rash that spreads across your body accompanied by blistering and peeling skin -Severe nervous system reaction which can cause very stiff muscles high fever sweating confusion fast uneven heartbeats tremors feeling like you might pass out.
Always consult your healthcare provider if any adverse reactions occur while taking these medications.
What are the most common side effects for Luvox?
Luvox, also known as Fluvoxamine, can cause several side effects that may include:
- Dry mouth or changes in appetite
- Nausea and possible stomach upset
- Sleep disturbances such as insomnia or unusual dreams
- Sweating excessively and feeling anxious
- Changes in heartbeat rate
- A sense of confusion or agitation
- Possible skin rash
- Slight weight loss due to changes in appetite
- Frequent urination
- Headache, dizziness or unsteadiness -Difficulty with muscle control or coordination.
However, these potential side effects vary between individuals. Always consult your healthcare provider for personalized advice regarding medications.
Are there any potential serious side effects for Luvox?
Luvox, like all medications, can potentially cause side effects. You should immediately seek medical attention if you experience any of the following symptoms while taking Luvox:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face or throat
- Worsening depression or unusual changes in mood or behavior, including new or increased feelings of anxiety, panic attacks, trouble sleeping
- Increased suicidal thoughts especially among teenagers and young adults
- Racing heartbeats and chest pain
- Unusual bruising, bleeding easily
- Changes in weight or appetite
- Symptoms associated with serotonin syndrome: agitation,hallucination (seeing things that aren't there), loss of coordination, fast heartbeat, severe nausea/vomiting/diarrhea.
These are not all the potential side effects of Luvox. Any new physical or psychological symptom should be reported to your healthcare provider right away.
Contraindications for Cymbalta and Luvox?
Like most antidepressant medications, both Cymbalta and Luvox may inadvertently worsen symptoms of depression in certain individuals. If you notice a worsening in your depressive symptoms or an increase in suicidal thoughts or behaviors while taking these medications, it is crucial to seek immediate medical attention.
It's important to note that neither Cymbalta nor Luvox should be taken if you are currently on, or have recently stopped taking monoamine oxidase inhibitors (MAOIs). Always inform your healthcare provider about all the medications you're currently using; MAOIs will require a washout period of approximately 5 weeks from your system to prevent hazardous interactions with either Cymbalta or Luvox.
How much do Cymbalta and Luvox cost?
For the brand name versions of these drugs:
- The price for 30 capsules of Cymbalta (60 mg) averages around $270, which works out to approximately $9/day.
- The price for 100 tablets of Luvox (50 mg) is about $130, working out to roughly $1.3/day.
Thus, if you are in a higher dosage range for Cymbalta (i.e., 120 mg/day), then brand-name Luvox is less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these drugs is right for you.
For the generic versions of Cymbalta (duloxetine) and Luvox (fluvoxamine), costs are significantly lower:
- Duloxetine is available in packs of 30 capsules and above, with approximate costs ranging from $0.20 to $0.80 per day depending on your dose.
- Fluvoxamine can be found in packs from 15 up to several hundred tablets, with the cost starting at around $0.09/day and generally not exceeding about $0.70/day based on typical dosing ranges.
Popularity of Cymbalta and Luvox
Duloxetine, also known by the brand name Cymbalta, was prescribed to approximately 10 million people in the US in 2020. Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), and accounted for about 22% of SNRI prescriptions in the country. Although it's not classified as an SSRI, it remains one of the most commonly prescribed antidepressants. The prevalence of duloxetine has been steadily increasing since its introduction.
Fluvoxamine, including brand versions such as Luvox, was prescribed to around 1 million people in the USA during the same year. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) and represents just under 2% of overall SSRI prescriptions in America. Over time, fluvoxamine's prescription rate has remained relatively steady with minor fluctuations.
Conclusion
Both Cymbalta (duloxetine) and Luvox (fluvoxamine) have established use in the treatment of depression as well as anxiety disorders, with ample evidence from clinical trials supporting their effectiveness over placebo treatments. Co-administration of these drugs is possible but should be done under careful medical supervision due to potential interactions. They work differently; Cymbalta acts mainly on serotonin and norepinephrine while Luvox primarily affects serotonin levels.
Cymbalta is often a first-line option for treating depression and certain types of chronic pain, whereas Luvox is more commonly used for obsessive-compulsive disorder (OCD) and social anxiety disorder. Both are available in generic form which can mean significant cost reductions for patients who are self-funding.
An adjustment period may be needed when starting either drug, meaning that therapeutic effects might not become apparent immediately after beginning treatment.
The side effect profiles between the two medications have similarities but differ somewhat too - both can cause nausea, sweating or dry mouth, but sexual dysfunction or weight changes tend to be less common with Luvox than Cymbalta. Regular mood monitoring is crucial when using these medications to ensure they're beneficial without exacerbating symptoms; immediate professional help should be sought if there's any worsening of depressive symptoms or emergence of suicidal thoughts.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Frampton, J. E., & Plosker, G. L. (2007). Duloxetine. CNS Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00023210-200721070-00004
- Gupta, S., Nihalani, N., & Masand, P. (2007, April). Duloxetine: Review of Its Pharmacology, and Therapeutic Use in Depression and Other Psychiatric Disorders. Annals of Clinical Psychiatry. Portico.http://doi.org/10.1080/10401230701333319
- Prakash, A., Lobo, E., Kratochvil, C. J., Tamura, R. N., Pangallo, B. A., Bullok, K. E., … March, J. S. (2012, February). An Open-Label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression. Journal of Child and Adolescent Psychopharmacology. Mary Ann Liebert Inc.http://doi.org/10.1089/cap.2011.0072
- Dhillon, S. (2012, December 14). Duloxetine. Drugs & Aging. Springer Science and Business Media LLC.http://doi.org/10.1007/s40266-012-0040-1
- Johansen, A. N., Stenzhorn, A. A., Rosenzweig, M., Thirstrup, S., & Gazerani, P. (2013, July 24). Prescribing patterns and safety monitoring of duloxetine using the Danish Register of Medicinal Product Statistics as a source. Scandinavian Journal of Public Health. SAGE Publications.http://doi.org/10.1177/1403494813496599